Navigation Links
United Therapeutics Corporation To Announce First Quarter 2013 Financial Results Before Market Open On Thursday, April 25, 2013
Date:4/18/2013

SILVER SPRING, Md., April 18, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2013 financial results before market open on Thursday, April 25, 2013.

United Therapeutics will host a half-hour teleconference on Thursday, April 25, 2013, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using conference code: 32040188.

This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions.


'/>"/>
SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. National Honey Board Seeks Board Member Nominees: Appointments to be Made by United States Secretary of Agriculture
2. Entia Receives Notices of Allowance for its Ergothioneine and Genetic Transporter Patents from the United States, Canada, and Israel
3. Seven Outstanding Doctors Receive Honors From The United States & Canadian Academy of Pathology
4. United States Patent and Trademark Office to Require Signed NDA Affects Many Reports Wysebridge
5. United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
6. United Therapeutics Announces Additional $420 Million Share Repurchase Program
7. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
8. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
9. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
10. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
11. New Approach to Growing Waste to Value Industry in United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/17/2018)... ... August 17, 2018 , ... VANCOUVER, British Columbia, Canada, August ... pleased to announce the release of the Russian translation of Best Practices: Recommendations ... 2018, is a practice-changing publication aimed at advancing the science of biobanking to ...
(Date:8/14/2018)... , ... August 14, 2018 , ... ... impetus at the 11th Congress of the Chinese Association of Orthopaedic Surgeons (CAOS) ... Fule Science & Technology Development , Beijing, and Invibio Biomaterial Solutions ...
(Date:8/9/2018)... ... 2018 , ... ActX introduces GenoACT(sm), a Genetic Clinical Decision ... talented scientific team that includes geneticists, PharmD’s, genetic counselors, and physicians aided by ... medical impact of a patient’s genetic variants , 2. Educational information for clinicians, ...
(Date:8/9/2018)... ... 09, 2018 , ... MedEvolve, Inc. , a national ... software and services for physician practices, announced today the company’s bookings for second ... record quarters in Q2 and Q3 last year, the company has exceeded those ...
Breaking Biology Technology:
(Date:8/2/2018)... ... August 02, 2018 , ... RxS LLC (“RxS”), a ... today announced that Mark Jara, principal of the organization, has been named to ... industry. Individuals named to PharmaVOICE 100 are leaders who drive the industry forward ...
(Date:8/1/2018)... ... August 01, 2018 , ... Clinical ... LPN’s, MA's and Administrative staff. , This full day course is an interactive ... course will expose your staff to regenerative medicine procedures and processing techniques, and ...
(Date:7/31/2018)... ... 31, 2018 , ... Lifecycle Biotechnologies, a leading life science ... this role, Mr. Muzek will lead the company-wide industrial strategic business development efforts ... , With over 20 years in business development, Mr. Muzek previously served as ...
Breaking Biology News(10 mins):